"No-touch" Viscoexpression Removal of Ozurdex Implant

A 45-year-old male with a history of complicated cataract surgery presented with diminished vision one week after receiving an intravitreal dexamethasone (Ozurdex) implant. On slit-lamp evaluation, anterior migration of the implant was revealed. As these implants are friable, and breaking one could cause steroid-induced glaucoma, Drs. Sonam Yangzes, Surinder Singh Pandav, and Faisal Thattaruthody opted for a "no-touch" removal technique using viscoelastic to direct the implant and push it out a side port. One month after removal, the patient's visual acuity improved to 20/30 (6/9).

Financial Disclosures: Dr. Sonam Yangzes discloses no financial relationships. Dr. Surinder Singh Pandav discloses no financial relationships. Dr. Faisal Thattaruthody discloses no financial relationships.